Centers for Disease Control and Prevention. (2021). Blastomycosis: Epidemiology and Risk Factors. Atlanta, GA: CDC.
[2]
Kauffman, C. A. (2019). Blastomycosis. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (9th ed.). Philadelphia: Elsevier.
[3]
McBride, J. A., et al. (2017). Clinical Manifestations of Disseminated Blastomycosis. Clinical Infectious Diseases, 65(5), 721-728.
[4]
Chapman, S. W., et al. (2008). Clinical Practice Guidelines for the Management of Blastomycosis. Clinical Infectious Diseases, 46(12), 1801-1812.
[5]
Bariola, J. R., & Varkey, J. B. (2019). Blastomycosis: A Review of Clinical Manifestations and Diagnosis. Journal of Fungi, 5(3), 67.
[6]
Klein, B. S., & Tebbets, P. (2017). Blastomyces dermatitidis: Virulence Factors and Immune Response. Medical Mycology, 45(5), 399-406.
[7]
Mekha, N., et al. (2020). Disseminated Blastomycosis in Immunocompromised Patients. Open Forum Infectious Diseases, 7(8), ofaa302.
[8]
Saccente, M., & Woods, G. L. (2010). Clinical and Laboratory Update on Blastomycosis. Clinical Microbiology Reviews, 23(2), 367-381.